Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Chemotherapy characteristics are important predictors of primary prophylactic CSF administration in older patients with breast cancer.

Breast cancer research and treatment - 1 Jun 2011

Rajan Suja S, Lyman Gary H, Carpenter William R, Stearns Sally C

Abstract excerpt

Chemotherapy is vital for breast cancer management, but early onset toxicities like neutropenia hinder its administration. Primary prophylactic (PP) use of colony- stimulating factors (CSF) helps prevent neutropenia and ensures successful chemotherapy completion. Nevertheless, lack of specific gu...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Antineoplastic Agents
Share to Antineoplastic Combined Chemotherapy Protocols

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Colony-Stimulating Factors

Share to Phenotype

Share to SEER Program

Source

Identifiers

PMID: 20976544
DOI: 10.1007/s10549-010-1216-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20976544-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Chemotherapy characteristics are important predictors of primary prophylactic CSF administration in older patients with breast cancer.PMID 20976544Read ↗

Pharmacologic rationale for early G-CSF prophylaxis in cancer patients and role of pharmacogenetics in treatment optimization.Semantic proximity Read ↗

Infectious Complications of Cyclin-Dependent Kinases 4 and 6 Inhibitors in Patients With Hormone Receptor-Positive Metastatic Breast Cancer: A Systematic Review and Meta-analysisSemantic proximity Read ↗

Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genetic risk factors.Semantic proximity Read ↗

Comparison of Efficacy and safety of Tinapeg® vs. Neulastim® to prevent chemotherapy-induced neutropenia in breast cancer patients: randomized, parallel, equivalence, multicentric and Phase III clinical trial studySemantic proximity Read ↗

Racial Disparities in Neutrophil Counts Among Patients with Metastatic Breast Cancer during Treatment with CDK4/6 InhibitorsSemantic proximity Read ↗

Importance of standard precautions to febrile neutropenia prevention in patients with cancer during COVID 19 outbreakSemantic proximity Read ↗

Determinants of surgeon referral and radiation therapy receipt following breast conservation among older women with early-stage breast cancerSemantic proximity Read ↗

Factors Associated with Financial Toxicity in Patients with Breast Cancer in Japan: A Comparison of Patient and Physician PerspectivesSemantic proximity Read ↗

The Impact of Surgeon Referral and a Radiation Oncologist Productivity-Based Metric on Radiotherapy Receipt Among Elderly Women with Early-Stage Breast Cancer: Analysis from a Tertiary Cancer NetworkSemantic proximity Read ↗

Pharmacogenetic association between GSTP1 genetic polymorphism and febrile neutropenia in Japanese patients with early breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.